Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals
Event: Heart Failure 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Cardiac amyloidosis from epidemiology to treatment
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Registries and Trial updates I
Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed?
Off hours versus on hours presentation in ST-segment elevation myocardial infarction: findings from CHAMPION PHOENIX
Event: ESC Congress 2016
Topic: Infarction acute phase STEMI
Session: Time and space in acute coronary syndrome
ESC 365 is supported by
